Variants in the FFAR1 gene are associated with beta cell function
- PMID: 17987108
- PMCID: PMC2042513
- DOI: 10.1371/journal.pone.0001090
Variants in the FFAR1 gene are associated with beta cell function
Abstract
Background: The FFAR1 receptor is expressed mainly in pancreatic beta cells and is activated by medium to long chain free fatty acids (FFAs), as well as by thiazolidinediones, resulting in elevated Ca(2+) concentrations and promotion of insulin secretion. These properties suggest that FFAR1 could be a mediator of lipotoxicity and a potential candidate gene for Type 2 diabetes (T2D). We therefore investigated whether variations at the FFAR1 locus are associated with T2D and beta cell function.
Methodology/principal findings: We re-sequenced the FFAR1 region in 96 subjects (48 healthy and 48 T2D individuals) and found 13 single nucleotide polymorphisms (SNPs) 8 of which were not previously described. Two SNPs located in the upstream region of the FFAR1 gene (rs1978013 and rs1978014) were chosen and genotyped in 1929 patients with T2D and 1405 healthy control subjects. We observed an association of rs1978013 and rs1978014 with insulinogenic index in males (p = 0.024) and females (p = 0.032), respectively. After Bonferroni corrections, no association with T2D was found in the case-control material, however a haplotype consisting of the T-G alleles conferred protection against T2D (p = 0.0010).
Conclusions/significance: Variation in the FFAR1 gene may contribute to impaired beta cell function in T2D.
Conflict of interest statement
Similar articles
-
Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysis.PLoS One. 2011 Apr 28;6(4):e19146. doi: 10.1371/journal.pone.0019146. PLoS One. 2011. PMID: 21552566 Free PMC article.
-
Suppression of free fatty acid receptor 1 expression in pancreatic β-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1.Endocr J. 2019 Jan 28;66(1):43-50. doi: 10.1507/endocrj.EJ18-0203. Epub 2018 Oct 17. Endocr J. 2019. PMID: 30333365
-
Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.Mol Metab. 2017 Oct;6(10):1304-1312. doi: 10.1016/j.molmet.2017.07.007. Epub 2017 Jul 18. Mol Metab. 2017. PMID: 29031729 Free PMC article.
-
Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus.Mini Rev Med Chem. 2021;21(4):426-470. doi: 10.2174/1389557520666201023141326. Mini Rev Med Chem. 2021. PMID: 33100202 Review.
-
Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes.J Intern Med. 2020 Aug;288(2):158-167. doi: 10.1111/joim.13049. Epub 2020 May 3. J Intern Med. 2020. PMID: 32363639 Review.
Cited by
-
G protein-coupled receptors as targets for anti-diabetic therapeutics.Nat Rev Drug Discov. 2016 Mar;15(3):161-72. doi: 10.1038/nrd.2015.4. Epub 2016 Jan 29. Nat Rev Drug Discov. 2016. PMID: 26822831 Review.
-
Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges.Nat Rev Endocrinol. 2021 Mar;17(3):162-175. doi: 10.1038/s41574-020-00459-w. Epub 2021 Jan 25. Nat Rev Endocrinol. 2021. PMID: 33495605 Review.
-
The pancreatic beta cell surface proteome.Diabetologia. 2012 Jul;55(7):1877-89. doi: 10.1007/s00125-012-2531-3. Epub 2012 Mar 31. Diabetologia. 2012. PMID: 22460761 Free PMC article. Review.
-
Minireview: The effects of species ortholog and SNP variation on receptors for free fatty acids.Mol Endocrinol. 2013 Aug;27(8):1177-87. doi: 10.1210/me.2013-1085. Epub 2013 May 17. Mol Endocrinol. 2013. PMID: 23686113 Free PMC article. Review.
-
Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.Diabetes. 2013 Jun;62(6):2106-11. doi: 10.2337/db12-1249. Epub 2013 Feb 1. Diabetes. 2013. PMID: 23378609 Free PMC article.
References
-
- Groop L. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion. Int J Clin Pract. 2000;(Suppl):3–13. - PubMed
-
- LeRoith D. Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. Am J Med. 2002;113(Suppl 6A):3S–11S. - PubMed
-
- Del Prato S, Marchetti P. Beta- and alpha-cell dysfunction in type 2 diabetes. Horm Metab Res. 2004;36:775–781. - PubMed
-
- Ahren B. Type 2 diabetes, insulin secretion and beta-cell mass. Curr Mol Med. 2005;5:275–286. - PubMed
-
- Manco M, Calvani M, Mingrone G. Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab. 2004;6:402–413. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous